Sign In
Buy MGNX
$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
12:00am, Tuesday, 12'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Amyris Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc. Read Harry Boxer's latest article on Investing.com
Why MacroGenics Stock Jumped 29% Today
08:37pm, Monday, 11'th May 2020
Optimism is growing ahead of the release of abstracts this week for the upcoming ASCO 2020 conference.
Optimism Runs High for MacroGenics
03:14pm, Monday, 11'th May 2020
Stock soars on promising early trial data for key drugs Continue reading...
3 Small-Cap Biotech Stocks That Surged Last Week
10:29am, Monday, 11'th May 2020
Last week, shares of these three biotech stocks rocketed higher, but their market values are still relatively small. Here's what you need to know about the businesses behind these recent stock market
Why MacroGenics, Inc.'s (NASDAQ:MGNX) CEO Pay Matters To You
12:10pm, Friday, 08'th May 2020
In 2001, Scott Koenig was appointed CEO of MacroGenics, Inc. (NASDAQ:MGNX). First, this article will compare CEO...
Analysts Have Made A Financial Statement On MacroGenics, Inc.'s (NASDAQ:MGNX) First-Quarter Report
11:34am, Friday, 08'th May 2020
As you might know, MacroGenics, Inc. (NASDAQ:MGNX) just kicked off its latest quarterly results with some very strong...
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Macrogenics Inc (MGNX) Q1 2020 Earnings Call Transcript
07:01pm, Wednesday, 06'th May 2020
MGNX earnings call for the period ending March 31, 2020.
Mid-Afternoon Market Update: NASDAQ Jumps Over 100 Points; Nautilus Shares Plummet
06:35pm, Wednesday, 06'th May 2020Here's Why MacroGenics Stock Is Skyrocketing 171% Today
05:24pm, Wednesday, 06'th May 2020
After MacroGenics (NASDAQ: MGNX) updated investors on its clinical-stage drug pipeline and current financial position, its shares are soaring 171% as of 12:45 am EDT Wednesday. After the market's cl
